Publications by authors named "Gregory A Gordon"

Claim this Profile
A
A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies.
Jonathan W Goldman, Robert N Raju, Gregory A Gordon, Iman El-Hariry, Florentina Teofilivici

BMC Cancerยท March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis